432 related articles for article (PubMed ID: 32401962)
21. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
Machiels JD; Bleeker-Rovers CP; Ter Heine R; Rahamat-Langendoen J; de Mast Q; Ten Oever J; Bousema T; van Crevel R; Wertheim HF
Int J Antimicrob Agents; 2020 Jul; 56(1):106056. PubMed ID: 32674929
[TBL] [Abstract][Full Text] [Related]
22. BET 2: Hydroxychloroquine in the treatment of COVID-19.
Howard L; Baombe J; Reynard C
Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
[No Abstract] [Full Text] [Related]
23. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
Keshtkar-Jahromi M; Bavari S
Am J Trop Med Hyg; 2020 May; 102(5):932-933. PubMed ID: 32247318
[No Abstract] [Full Text] [Related]
24. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Jakhar D; Kaur I
Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
[No Abstract] [Full Text] [Related]
25. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
Lebin JA; LeSaint KT
West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
[TBL] [Abstract][Full Text] [Related]
26. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials.
Shittu MO; Afolami OI
Infez Med; 2020 Ahead of print Jun 1; 28(2):192-197. PubMed ID: 32335560
[TBL] [Abstract][Full Text] [Related]
27. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
Ibáñez S; Martínez O; Valenzuela F; Silva F; Valenzuela O
Clin Rheumatol; 2020 Aug; 39(8):2461-2465. PubMed ID: 32495226
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Meo SA; Klonoff DC; Akram J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
[TBL] [Abstract][Full Text] [Related]
29. Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19.
Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC;
Asia Pac J Ophthalmol (Phila); 2020; 9(2):85-87. PubMed ID: 32349115
[TBL] [Abstract][Full Text] [Related]
30. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
Mvumbi DM
Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
[No Abstract] [Full Text] [Related]
31. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
Piszczatoski CR; Powell J
Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
[TBL] [Abstract][Full Text] [Related]
32. Drug Evaluation during the Covid-19 Pandemic.
Rome BN; Avorn J
N Engl J Med; 2020 Jun; 382(24):2282-2284. PubMed ID: 32289216
[No Abstract] [Full Text] [Related]
33. COVID-19 and hydroxychloroquine: Is the wonder drug failing?
Paliani U; Cardona A
Eur J Intern Med; 2020 Aug; 78():1-3. PubMed ID: 32553587
[No Abstract] [Full Text] [Related]
34. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
Pimentel J; Andersson N
Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
[TBL] [Abstract][Full Text] [Related]
35. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
Guzman-Prado Y
Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
[No Abstract] [Full Text] [Related]
36. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
Kim AHJ; Sparks JA; Liew JW; Putman MS; Berenbaum F; Duarte-García A; Graef ER; Korsten P; Sattui SE; Sirotich E; Ugarte-Gil MF; Webb K; Grainger R;
Ann Intern Med; 2020 Jun; 172(12):819-821. PubMed ID: 32227189
[TBL] [Abstract][Full Text] [Related]
37. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
[TBL] [Abstract][Full Text] [Related]
38. The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the question.
Cirino G; Ahluwalia A
Br J Pharmacol; 2020 Aug; 177(15):3361-3362. PubMed ID: 32602956
[No Abstract] [Full Text] [Related]
39. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
Jeevaratnam K
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
[No Abstract] [Full Text] [Related]
40. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
